MANZI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 792
EU - Europa 495
AS - Asia 140
AF - Africa 16
SA - Sud America 4
Totale 1.447
Nazione #
US - Stati Uniti d'America 788
IT - Italia 313
SG - Singapore 76
SE - Svezia 68
IN - India 33
DE - Germania 25
FR - Francia 19
CN - Cina 18
NL - Olanda 16
TG - Togo 15
FI - Finlandia 13
GB - Regno Unito 11
BG - Bulgaria 9
RO - Romania 7
IR - Iran 6
AR - Argentina 4
CA - Canada 4
UA - Ucraina 4
ES - Italia 2
HK - Hong Kong 2
IE - Irlanda 2
JP - Giappone 2
RU - Federazione Russa 2
TW - Taiwan 2
AT - Austria 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
Totale 1.447
Città #
Rome 126
Fairfield 108
Chandler 78
Ashburn 62
Woodbridge 47
Singapore 46
Seattle 44
Cambridge 41
Houston 34
Wilmington 32
Princeton 25
Milan 21
San Diego 21
Dearborn 18
Lomé 15
San Paolo di Civitate 15
Groningen 13
Lawrence 13
Boston 11
Millbury 11
Sofia 9
Beijing 8
Santa Clara 8
Andover 7
Paris 7
Fremont 6
Helsinki 6
Norwalk 6
Plano 6
Rende 5
Bonate Sotto 4
Carrara 4
Formia 4
Leawood 4
Redwood City 4
Ann Arbor 3
Blackburn 3
Bologna 3
Chennevières-sur-marne 3
Federal 3
Florence 3
Lappeenranta 3
Lavis 3
London 3
Naples 3
Southend 3
Toronto 3
Zanjan 3
Bari 2
Bergamo 2
Bremen 2
Cardito 2
Cremona 2
Des Moines 2
Dublin 2
Foligno 2
Fort Worth 2
Hyderabad 2
Lecce 2
Mannheim 2
Meppel 2
Nanjing 2
New Taipei 2
New York 2
Pamplona 2
Romainville 2
Saint-Fons 2
San Mateo 2
Tottori-shi 2
Varese 2
West Jordan 2
Wolfenbüttel 2
Agropoli 1
Alatri 1
Albignasego 1
Almaty 1
Arnsberg 1
Atlanta 1
Bitonto 1
Boardman 1
Bovisio Masciago 1
Buenos Aires 1
Buscate 1
Civitavecchia 1
Curtarolo 1
Duncan 1
Genazzano 1
Hefei 1
Henderson 1
Hounslow 1
Huzhou 1
Jacksonville 1
Jinan 1
Kunming 1
Marone 1
Maruggio 1
Molochio 1
Nanchang 1
New Bedfont 1
Nürnberg 1
Totale 984
Nome #
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 117
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 103
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 99
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 93
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 93
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 89
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 70
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 69
Management of cardiac implantable electronic device follow-up in COVID-19 pandemic. Lessons learned during Italian lockdown 55
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 55
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 53
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 51
The importance of right ventricular function in patients with pulmonary arterial hypertension 50
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up 49
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis 46
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension 44
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 40
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension 37
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era. is risk of disease progression around the corner 32
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension 32
Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china 30
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 28
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution). proposal of a study protocol aimed to realize a validated risk score for early diagnosis 25
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension 24
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension 24
Gaps of evidence in pulmonary arterial hypertension 24
Comment on topyła-putowska et al. echocardiography in pulmonary arterial hypertension. comprehensive evaluation and technical considerations. j. clin. med. 2021, 10, 3229 21
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension. determinants and clinical impact 18
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension 17
Biobanks: the unmet need in heart failure management 14
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 14
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension. a systematic review and network meta-analysis 10
Phenotypes of idiopathic pulmonary arterial hypertension 8
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience 8
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing 7
Right ventricular/pulmonary artery coupling in patients with heart failure with preserved ejection fraction. a clue for pulmonary hypertension 7
Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients 7
Totale 1.563
Categoria #
all - tutte 6.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 5 0 11 15 29 29 24 22 13 4 11
2020/2021204 11 15 4 3 3 8 3 12 42 70 18 15
2021/2022340 24 16 3 20 17 16 4 24 45 31 81 59
2022/2023394 50 73 35 37 43 48 4 20 51 5 19 9
2023/2024279 18 37 35 15 28 22 14 22 5 28 30 25
2024/202554 20 34 0 0 0 0 0 0 0 0 0 0
Totale 1.563